NIH PAR · ODP · R01
PAR-25-098: Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations that experience health disparities. Interventions should include screening, preventive services, or other healthcare processes, including timely follow-up of abnormal findings, and referral to accessible care. Projects are encouraged to leverage collaborations with community partners and service providers. Interventions should address barriers and facilitators at two or more of the following…
- NOFO number
- PAR-25-098
- Type
- PAR
- Activity code
- R01
- Primary institute
- ODP
- Clinical trials
- Required
- Posted
- Oct 10, 2024
- Opens
- Nov 21, 2024
- Expires
- Jan 8, 2027
PAR-25-098 due dates
No application due dates remain in the listed cycles. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 05, 2025 | March 05, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 05, 2025 | July 05, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 05, 2025 | November 05, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 05, 2026 | March 05, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 05, 2026 | July 05, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 05, 2026 | November 05, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
Projects funded under PAR-25-098
NIH RePORTER lists 1 project funded under PAR-25-098 in FY2022–FY2026, with $490K in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
1
Distinct projects, FY2022–FY2026
New awards
1
Type 1 (new project) award records
NIH funding
$490K
Award dollars under PAR-25-098, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 1 | 1 | $490K |
Institutions with the most funding
- Icahn School of Medicine at Mount Sinai$490K · 1 project
Funding institutes
- NIMHD$490K · 1
Activity codes funded
- R011 record
Most recent new awards
- EXPAND-PC: Expanding Prostate Cancer Screening and Improving Delivery of Preventive Services in Community Settings (opens NIH RePORTER)
Icahn School of Medicine at Mount Sinai · 1R01MD021739-01A1 · NIMHD · Notice Jul 21, 2026
$490KR01
What its predecessor PAR-23-170 funded
PAR-25-098 reissues PAR-23-170. Its funding history is the best guide to who wins under this program: 4 projects and $4.7M in FY2022–FY2026.
Projects funded
4
Distinct projects, FY2022–FY2026
New awards
4
Type 1 (new project) award records
NIH funding
$4.7M
Award dollars under PAR-23-170, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 4 | 4 | $2.7M |
| FY2026 | 3 | 0 | $2.0M |
Institutions with the most funding
- Boston Medical Center$1.4M · 1 project
- George Washington University$1.4M · 1 project
- Georgetown University$1.2M · 1 project
- University of Colorado Denver$659K · 1 project
- Harvard University D/B/A Harvard School of Public Health$1 · 1 project
Funding institutes
- NCI$3.3M · 6
- NIMHD$1.4M · 1
Activity codes funded
- R017 records
Most recent new awards
- mHealth Navigation using SMS Texting to Improve Colorectal Cancer Screening Among Homeless Persons (opens NIH RePORTER)
George Washington University · 1R01MD019112-01A1 · NIMHD · Notice Sep 19, 2025
$1.4MR01
- Increasing CRC Screening in Community Health Centers through Mobile Messaging Optimization (opens NIH RePORTER)
Harvard University D/B/A Harvard School of Public Health · 1R01CA293501-01A1 · NCI · Notice Apr 18, 2025
$1R01
- Bundled Multicancer Screening and Genetic Services Navigation to Improve Cancer Outcomes (opens NIH RePORTER)
Georgetown University · 1R01CA301168-01 · NCI · Notice Apr 17, 2025
$547KR01
- Development of Systems and Education for Cervical Cancer prevention (DOSE-CC) (opens NIH RePORTER)
Boston Medical Center · 1R01CA299475-01 · NCI · Notice Apr 17, 2025
$753KR01
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
5 NIH institutes and offices take applications under PAR-25-098. Contact the program officer at the institute that fits your research before applying.
- ODP
- NIDCR · National Institute of Dental and Craniofacial Research
- NIMHD · National Institute on Minority Health and Health Disparities
- NCI · National Cancer Institute
- ORWH
Related notices
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy. See Notice NOT-OD-22-189.
Award terms
- Application types allowed
- NewRenewalResubmission The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are not limited but need to reflect the actual needs of the proposed project.
- Project period
- The scope of the proposed project should determine the project period.  The maximum project period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-23-170.
Other open NOFOs for R01
- PAR-26-001Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)ODP · next due Feb 5, 2027
- PAR-25-379Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)NIDA · next due Oct 21, 2026
- PAR-25-317Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)NIMHD · next due Feb 5, 2027
- PAR-25-144Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)NCI · next due Feb 5, 2027
- PAR-24-273Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional)NIMHD · next due Feb 5, 2027
- PAR-25-077CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)NINDS · next due Oct 16, 2026
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.